Receiver operating curve analysis also demonstrated that TMEM52B expression was a predictive marker for overall survival (Figure 1H) and recurrence versus no recurrence in NPC patients (Figure 1J), and was a diagnostic indicator for discriminating advanced stages (stages III and IV) from early stages (stages I and II) (Figure 1I). This evidence concerns the gene TMEM52B and nasopharyngeal carcinoma.